Newsfeeds Archive - Page 8 of 8

1 minute read

Raymond James Maintains Outperform on Harmony Biosciences, Raises Price Target to $60

August 3, 5:10 AM

Raymond James analyst Danielle Brill maintains Harmony Biosciences (NASDAQ:HRMY) with a Outperform and raises the price target from $58 to $60.

17 minute read

August 2, 4:37 AM

Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.

1 minute read

July 13, 5:51 AM

Goldman Sachs analyst Corinne Jenkins downgrades Harmony Biosciences (NASDAQ:HRMY) from Buy to Neutral and announces $55 price target.

18 minute read

July 7, 10:04 AM

Upgrades

1 minute read

July 7, 5:06 AM

Mizuho analyst Graig Suvannavejh initiates coverage on Harmony Biosciences (NASDAQ:HRMY) with a Buy rating and announces Price Target of $64.